APA Цитирование

Pilewskie, M., Stempel, M., Rosenfeld, H., Eaton, A., Van Zee, K. J., & Morrow, M. (2016). Do LORIS trial eligibility criteria identify a ductal carcinoma in situ (DCIS) patient population at low risk of upgrade to invasive carcinoma? Ann Surg Oncol.

Chicago-стиль цитирования

Pilewskie, Melissa, Michelle Stempel, Hope Rosenfeld, Anne Eaton, Kimberly J. Van Zee, and Monica Morrow. "Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma in Situ (DCIS) Patient Population At Low Risk of Upgrade to Invasive Carcinoma?" Ann Surg Oncol 2016.

MLA-цитирование

Pilewskie, Melissa, et al. "Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma in Situ (DCIS) Patient Population At Low Risk of Upgrade to Invasive Carcinoma?" Ann Surg Oncol 2016.

Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.